Author details

Full Name

William F Simonds

Affiliation

ORCID

Career Start Year

1975

Papers

140

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36255737	Ancestry-specific high-risk gene variant profiling unmasks diabetes-associated genes.	Hum Mol Genet	2024
37219953	Specific regulation of mechanical nociception by GÎ²5 involves GABA-B receptors.		2023
37885910	A Knock-In Mouse Model of the Variant p.Y392S Develops Normal Parathyroid Glands.		2023
37409236	Expressions of Cushing's syndrome in multiple endocrine neoplasia type 1.		2023
37284613	Long-Term Outcomes of Parathyroid Autografts in Primary Hyperparathyroidism.	J Endocr Soc	2023
37339334	Phenotypic Profiling and Molecular Mechanisms in Hyperparathyroidism-jaw Tumor Syndrome.	J Clin Endocrinol Metab	2023
36961765	Molecular and Clinical Spectrum of Primary Hyperparathyroidism.		2023
35326576	Parathyroid Carcinoma: Incidence, Survival Analysis, and Management: A Study from the SEER Database and Insights into Future Therapeutic Perspectives.	Cancers	2022
36111275	Metastatic Grade 3 Neuroendocrine Tumor in Multiple Endocrine Neoplasia Type 1 Expressing Somatostatin Receptors.	J Endocr Soc	2022
35811576	Case of Recurrent Primary Hyperparathyroidism, Congenital Granular Cell Tumor, and Aggressive Colorectal Cancer.	Journal of the Endocrine Society	2022
34788508	Parathyroid Hormone Resistance and Autoantibodies to the PTH1 Receptor.	N Engl J Med	2021
33716975	Familial Hyperparathyroidism.	Frontiers in Endocrinology	2021
32756962	Patients With MEN1 Are at an Increased Risk for Venous Thromboembolism.	J Clin Endocrinol Metab	2021
33172956	Inhibition of G-protein signalling in cardiac dysfunction of intellectual developmental disorder with cardiac arrhythmia (IDDCA) syndrome.	J Med Genet	2021
34515662	Two distinct classes of thymic tumors in patients with MEN1 show LOH at the MEN1 locus.	Endocr Relat Cancer	2021
32590342	Genotype of CDC73 germline mutation determines risk of parathyroid cancer.		2020
32130200	18F-FDOPA PET/CT accurately identifies MEN1-associated pheochromocytoma.	Endocrinol Diabetes Metab Case Rep	2020
31782130	Long-term remission of disseminated parathyroid cancer following immunotherapy.	Endocrine	2020
32350052	Pitfalls of using denosumab preoperatively to treat refractory severe hypercalcaemia.	BMJ Case Reports	2020
32227318	Clinical and Molecular Genetics of Primary Hyperparathyroidism.	Hormone and Metabolic Research	2020
31044034	Retrospective study of inpatient diabetes management service, length of stay and 30-day readmission rate of patients with diabetes at a community hospital.	J Community Hosp Intern Med Perspect	2019
30452964	CDC73 Germline Mutation in a Family With Mixed Epithelial and Stromal Tumors.	Urology	2019
30414705	High prevalence of chronic kidney disease in patients with multiple endocrine neoplasia type 1 and improved kidney function after parathyroidectomy.	Surgery	2019
31480016	Clinical presentation and management of primary ovarian neuroendocrine tumor in multiple endocrine neoplasia type 1.	Endocrinol Diabetes Metab Case Rep	2019
31531399	Development of R7BP inhibitors through cross-linking coupled mass spectrometry and integrated modeling.	Communications Biology	2019
29408534	Probability of Positive Genetic Testing Results in Patients with Family History of Primary Hyperparathyroidism.	J Am Coll Surg	2018
29467239	Frequency and consequence of the recurrent <i>YY1</i> p.T372R mutation in sporadic insulinomas.	Endocr Relat Cancer	2018
29108698	Familial isolated primary hyperparathyroidism associated with germline GCM2 mutations is more aggressive and has a lesser rate of biochemical cure.	Surgery	2018
28134655	A central role for R7bp in the regulation of itch sensation.	Pain	2017
28476229	Genetics of Hyperparathyroidism, Including Parathyroid Cancer.		2017
29264504	Ethnicity of Patients With Germline <i>GCM2</i>-Activating Variants and Primary Hyperparathyroidism.	J Endocr Soc	2017
27588455	GNB5 Mutations Cause an Autosomal-Recessive Multisystem Syndrome with Sinus Bradycardia and Cognitive Disability.	Am J Hum Genet	2016
27340770	Optimization of genome editing through CRISPR-Cas9 engineering.	Bioengineered	2016
27207564	Endocrine neoplasms in familial syndromes of hyperparathyroidism.		2016
27464610	Reoperative Surgery in Patients with Multiple Endocrine Neoplasia Type 1 Associated Primary Hyperparathyroidism.	Ann Surg Oncol	2016
26542588	Limited Parathyroidectomy in Multiple Endocrine Neoplasia Type 1-Associated Primary Hyperparathyroidism: A Setup for Failure.	Ann Surg Oncol	2016
27523599	GNB5 Mutations Cause an Autosomal-Recessive Multisystem Syndrome with Sinus Bradycardia and Cognitive Disability.	Am J Hum Genet	2016
27745835	GCM2-Activating Mutations in Familial Isolated Hyperparathyroidism.	Am J Hum Genet	2016
27594983	A patient with MEN1 typical features and MEN2-like features.	Int J Endocr Oncol	2016
26206648	Results of (68)Gallium-DOTATATE PET/CT Scanning in Patients with Multiple Endocrine Neoplasia Type 1.	J Am Coll Surg	2015
25193712	Improving the specificity and efficacy of CRISPR/CAS9 and gRNA through target specific DNA reporter.	Journal of Biotechnology	2014
25444225	Hyperparathyroidism-jaw tumor syndrome: Results of operative management.	Surgery	2014
23722465	Utility of intraoperative parathyroid hormone monitoring in patients with multiple endocrine neoplasia type 1-associated primary hyperparathyroidism undergoing initial parathyroidectomy.	World J Surg	2013
23093487	Association of type-O blood with neuroendocrine tumors in multiple endocrine neoplasia type 1.	J Clin Endocrinol Metab	2013
23161871	Cerebellar abnormalities in mice lacking type 3 deiodinase and partial reversal of phenotype by deletion of thyroid hormone receptor Î±1.	Endocrinology	2013
21916912	Cushing's syndrome in multiple endocrine neoplasia type 1.	Clin Endocrinol (Oxf)	2012
22508712	Sleeping parathyroid tumor: rapid hyperfunction after removal of the dominant tumor.	J Clin Endocrinol Metab	2012
22350475	Preoperative localizing studies for initial parathyroidectomy in MEN1 syndrome: is there any benefit?	World J Surg	2012
22963808	Aromatase inhibitor treatment ofÂ menorrhagia and subsequent pregnancy in a patient with familial hyperparathyroidism-jaw tumor syndrome.	Fertility and Sterility	2012
22297294	The EIF4EBP3 translational repressor is a marker of CDC73 tumor suppressor haploinsufficiency in a parathyroid cancer syndrome.	Cell Death and Disease	2012